TY - JOUR
T1 - Membrane topology of CLN3, the protein underlying Batten disease
AU - Mao, Qinwen
AU - Foster, Brian J.
AU - Xia, Haibin
AU - Davidson, Beverly L.
N1 - Funding Information:
The authors are grateful for the help of Peter Snyder and Ronald E. Haskell in initiating these studies, members of the Davidson Laboratory for provocative discussions, and also to Steven L. Eliason and Nicholette Zeliadt for technical support and Christine McLennan for manuscript assistance. This work was supported by the NIH Medical Scientist Training Program (B.J.F.), the Batten Disease Support and Research Association (B.L.D.), and the Roy J. Carver Trust (B.L.D.).
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2003/4/24
Y1 - 2003/4/24
N2 - Juvenile neuronal ceroid lipofuscinosis, or Batten disease, is an autosomal recessive disorder characterized by progressive loss of motor and cognitive functions, loss of vision, progressively severe seizures, and death. The disease is associated with mutations in the gene CLN3, which encodes a novel 438 amino acid protein, the function of which is currently unknown. Protein secondary structure prediction programs suggest that the CLN3 protein has five to seven membrane-spanning domains (MSDs). To distinguish among a number of hypothetical models for the membrane topology of CLN3 we used in vitro translation of native, Flag epitope-labeled and glycosylation site-mutated CLN3 protein in the presence or absence of canine pancreatic microsomes. These were immunoprecipitated using antibodies specific for Flag or peptide sequences within CLN3 or left untreated. The results indicate that CLN3 contains five MSDs, an extracellular/intraluminal amino-terminus, and a cytoplasmic carboxy-terminus.
AB - Juvenile neuronal ceroid lipofuscinosis, or Batten disease, is an autosomal recessive disorder characterized by progressive loss of motor and cognitive functions, loss of vision, progressively severe seizures, and death. The disease is associated with mutations in the gene CLN3, which encodes a novel 438 amino acid protein, the function of which is currently unknown. Protein secondary structure prediction programs suggest that the CLN3 protein has five to seven membrane-spanning domains (MSDs). To distinguish among a number of hypothetical models for the membrane topology of CLN3 we used in vitro translation of native, Flag epitope-labeled and glycosylation site-mutated CLN3 protein in the presence or absence of canine pancreatic microsomes. These were immunoprecipitated using antibodies specific for Flag or peptide sequences within CLN3 or left untreated. The results indicate that CLN3 contains five MSDs, an extracellular/intraluminal amino-terminus, and a cytoplasmic carboxy-terminus.
KW - Batten disease
KW - Membrane-spanning domain
KW - Protein topology
UR - http://www.scopus.com/inward/record.url?scp=0037464472&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037464472&partnerID=8YFLogxK
U2 - 10.1016/S0014-5793(03)00284-9
DO - 10.1016/S0014-5793(03)00284-9
M3 - Article
C2 - 12706816
AN - SCOPUS:0037464472
VL - 541
SP - 40
EP - 46
JO - FEBS Letters
JF - FEBS Letters
SN - 0014-5793
IS - 1-3
ER -